*Background*: A number of markers of infectious and inflammatory diseases have been associated with schizophrenia. However previous investigations have not yielded definitive conclusions about the role of these agents in disease pathogenesis. Previous studies have been limited by the examination of single or small groups of agents within a single population.

*Methods*: In this study, we examine multiple antibodies to infectious agents and food antigens as well as protein markers of inflammation in well-characterized cohorts of individuals with established schizophrenia (those with a duration of illness at least two years, *N*  = 261), individuals with a recent onset of psychosis (within the previous two years, *N*  = 106), and non-psychiatric controls (*N*  = 233). Some individuals had markers evaluated at several time points and some markers were not measured in some individuals due to limited sample volumes. Linear regression methods were used to calculate the association between the markers in recent onset and in established schizophrenia patients in comparison with controls adjusting for demographic factors such as age, race, gender, and maternal education. Regression models were also adjusted for the performance of multiple measurements in samples obtained from the same individual at different time points.

*Results*: For the recent onset group, significant associations were found for IgG antibodies to measles (*t*  = 8.31, *p*  \< .001); markers of intestinal inflammation, gliadin (*t*  = 5.90, *p*  \< .001) and bovine casein (*t*  = 4.74, *p*  \< .001); human coronavirus (*t*  = 2.89, *p*  = .004); *Toxoplasma gondii* (*t*  = 2.20, *p*  = .029), and the group D retroviruses, Mason-Pfizer monkey virus (*t*  = 3.97, *p*  \< .001) and murine leukemia virus (*t*  = 3.27, *p*  = .001). For the established schizophrenia group, significant associations were found for a general marker of inflammation, C-reactive protein (*t*  = 7.47, *p*  = .001); IgG antibodies to wheat gliadin (*t*  = 2.58, *p*  = .010) and another marker of intestinal inflammation, *Saccharomyces cerevisiae* (*t*  = −2.78, *p*  \< .006), measles (*t*  = 2.37, *p*  = .018), Herpes simplex virus type 2 (*t*  = 2.56, *p*  = .011), and human coronavirus (2.67, *p*  = .008). No significant case control differences were found in either group for IgG antibodies to cytomegalovirus, Epstein-Barr Virus, varicella-zoster virus, or influenza A or influenza B viruses. Case control differences were not found in the levels of antibodies to Herpes simplex virus type 1. However, antibodies to this virus were associated with lower cognitive performance in the individuals with established schizophrenia and in controls.

*Conclusions*: These results indicate overlap between the markers of infectious and inflammatory diseases found in recent onset psychosis and those found in established schizophrenia. Markers of intestinal inflammation were elevated in both groups but a marker of systemic inflammation, C-reactive protein, was only elevated in the established schizophrenia patients. Future studies that assess patients from the start of the illness and throughout the illness course may further identify the infectious and inflammatory factors that contribute to disease pathogenesis.
